Proteome Sciences plc
PRM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£2,140 | -£1,193 | -£2,213 | -£933 |
| Dep. & Amort. | £414 | £407 | £430 | £196 |
| Deferred Tax | £0 | £0 | £0 | £220 |
| Stock-Based Comp. | £0 | £0 | £39 | £38 |
| Change in WC | £359 | £116 | £744 | -£220 |
| Other Non-Cash | £470 | £358 | £486 | -£2 |
| Operating Cash Flow | -£897 | -£312 | -£514 | -£8,961,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£58 | -£215 | -£9 | -£1,718,000 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | -£6,912,000 |
| Investing Cash Flow | -£58 | -£215 | -£9 | -£8,630,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £450 | £750 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | -£4,746,000 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£530 | -£302 | -£297 | -£17,075,000 |
| Financing Cash Flow | -£80 | £448 | -£297 | -£17,075,000 |
| Forex Effect | £170 | -£1 | £1 | £1,016,000 |
| Net Chg. in Cash | -£865 | -£80 | -£819 | -£33,650,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1,128 | £1,208 | £2,027 | £281,657,000 |
| End Cash | £263 | £1,128 | £1,208 | £248,007,000 |
| Free Cash Flow | -£955 | -£527 | -£523 | -£10,679,000 |